AYTU BIOPHARMA, INC Finance Lease, Weighted Average Discount Rate, Percent
AYTU BIOPHARMA, INC (AYTU) had Finance Lease, Weighted Average Discount Rate, Percent of 0.00% as of 2024-06-30, per its 10-K filed 2024-09-26.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent · last filed 2024-09-26
- 2024-06-30: Finance Lease, Weighted Average Discount Rate, Percent 0.00%.
- 2024-03-31: Finance Lease, Weighted Average Discount Rate, Percent 6.54%.
- 2023-12-31: Finance Lease, Weighted Average Discount Rate, Percent 6.54%.
- 2023-09-30: Finance Lease, Weighted Average Discount Rate, Percent 6.54%.
| Period end | Finance Lease, Weighted Average Discount Rate, Percent | Finance Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2024-06-30 | 0.00% 10-K · filed 2024-09-26 | |
| 2024-03-31 | 6.54% 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 6.54% 10-Q · filed 2024-02-14 | |
| 2023-09-30 | 6.54% 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 6.50% 10-K · filed 2024-09-26 | 6.54% 10-K · filed 2023-10-12 |
| 2023-03-31 | 6.54% 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 6.54% 10-Q · filed 2023-02-21 | |
| 2022-09-30 | 6.43% 10-Q/A · filed 2023-02-21 | |
| 2022-06-30 | 6.43% 10-K · filed 2023-10-12 | |
| 2022-03-31 | 6.43% 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 6.43% 10-Q · filed 2022-02-14 | |
| 2021-09-30 | 6.43% 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 6.41% 10-K · filed 2022-09-27 | |
| 2021-03-31 | 6.40% 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |